Drugs / 99mTccAbVCAM1-5
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04483167 | Sep 2020 → May 2023 | atherosclerosis | University Hospital, Grenoble | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 99mTccAbVCAM1-5 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04483167 ↗ |
| Modality | Diagnostic / imaging agent | “new imaging agent” NCT04483167 ↗ |
| Route | Intravenous | “intravenous injection of 99mTccAbVCAM1-5 with dose increase” NCT04483167 ↗ |